Sirolimus: a new promising immunosuppressive drug. Towards a rationale for its use in renal transplantation-Reference-Cited by-同舟云学术

Sirolimus: a new promising immunosuppressive drug. Towards a rationale for its use in renal transplantation

Published:2001-01-01 Issue:1 Volume:16 Page:18-20
ISSN:1460-2385
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:

Author:

Morelon Emmanuel¹,Mamzer‐Bruneel Marie‐France¹,Peraldi Marie‐Noëlle¹,Kreis Henri¹

Affiliation:

1. Service de Transplantation, Hôpital Necker, Paris, France

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ndt/article-pdf/16/1/18/25041740/160018.pdf

Reference19 articles.

1. Sehgal SN, Baker H, Vezina C. Rapamycin (AY‐22, 989) a new antifungal antibiotic. II. Fermentation, isolation and characterization. J Antibiot (Tokyo)1975; 28: 727–735

2. Martel RR, Klicius J, Galet S. Inhibition of the immune response by rapamycin, a new antifungal antibiotic. Can J Physiol1977; 55: 48–51

3. Tanaka H, Kuroda A, Marusawa et al. Structure of FK 506: a novel immunosuppressant isolated from Streptomyces. J Am Chem Soc1987; 109: 5031–5033

4. Abraham RT, Wiederrecht GJ. Immunopharmacology of rapamycin. Annu Rev Immunol1996; 14: 483–510

5. Ryffel B, Weber E, Mihatsch MJ. Nephrotoxicity of immunosuppressants in rats: Comparison of macrolides with cyclosporin. Exp Nephrol1994; 2: 324–333

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A prognostic model of idiopathic pulmonary fibrosis constructed based on macrophage and mitochondria-related genes;BMC Pulmonary Medicine;2024-04-12

2. A prognostic model of idiopathic pulmonary fibrosis was constructed based on macrophage-related genes and mitochondria-related genes;2023-11-20

3. The evolution and revolution of drug coated balloons in coronary angioplasty: An up‐to‐date review of literature data;Catheterization and Cardiovascular Interventions;2023-10-23

4. Proteins and their functionalization for finding therapeutic avenues in cancer: Current status and future prospective;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-03

5. Immunosuppressants Tacrolimus and Sirolimus revert the cardiac antifibrotic properties of p38-MAPK inhibition in 3D-multicellular human iPSC-heart organoids;Frontiers in Cell and Developmental Biology;2022-11-11